Belvedere Trading LLC Esperion Therapeutics, Inc. Call Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.46 - $7.3 $19,856 - $99,280
-13,600 Reduced 21.73%
49,000 $77,000
Q4 2022

Feb 14, 2023
BUY
$5.09 - $8.5 $318,634 - $532,100
62,600 New
62,600 $389,000
Q2 2022

Jul 21, 2022
SELL
$4.77 - $6.67 $126,404 - $176,755
-26,500 Closed
0 $0
Q1 2022

Apr 20, 2022
BUY
$3.34 - $5.56 $25,384 - $42,256
7,600 Added 40.21%
26,500 $127,000
Q4 2021

Jan 25, 2022
BUY
$4.81 - $11.92 $90,908 - $225,288
18,900 New
18,900 $71,000

Others Institutions Holding ESPR

# of Institutions
208
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $160M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email